News

1/30/12 PredictAD final review - excellent progress Read more » 12/15/11 Press release: From heterogeneous patient measurements towards earlier diagnosis in Alzheimer's disease Read more » 12/15/11 Press release: Biochemical signature predicts progression to Alzheimer's disease Read more » 12/13/11 Journal paper in Translational Psychiatry Read more » 8/22/11 PredictAD presented at the VHP NoE Newsletter Read more »

Contact Information

Scientific Coordinator
Jyrki Lötjönen
VTT Technical Research Centre of Finland
P.O. Box 1300
33101 Tampere
+358 20 722 3378
jyrki.lotjonen@vtt.fi

Press release: Biochemical signature predicts progression to Alzheimer's disease

12/15/11

A study led by Research Professor Matej Orešič from VTT Technical Research Centre of Finland suggests that Alzheimer’s disease is preceded by a molecular signature indicative of hypoxia and up-regulated pentose phosphate pathway. This indicator can be analysed as a simple biochemical assay from a serum sample months or even years before the first symptoms of the disease occur. In a healthcare setting, application of such an assay could therefore complement the neurocognitive assessment by the medical doctor and could be applied to identify the at-risk patients in need of further comprehensive follow-up.

The full press release is available as pdf here.

1/30/12 PredictAD final review - excellent progress
12/15/11 Press release: From heterogeneous patient measurements towards earlier diagnosis in Alzheimer's disease
12/15/11 Press release: Biochemical signature predicts progression to Alzheimer's disease
12/13/11 Journal paper in Translational Psychiatry
8/22/11 PredictAD presented at the VHP NoE Newsletter
8/10/11 PredictAD gave a strong contribution at ICAD 2011
8/10/11 PredicAD workshop was held in Kuopio
8/9/11 Article in the Journal of Alzheimer's Disease
2/4/11 KUOPIO EPILEPSY SYMPOSIUM 2011 & TEACHING COURSE
9/28/10 PredictAD was presented in MICCAI 2010 Workshop

Go to archive »